Skip to main content

Table 2 Response to treatment, disease progression, and survival

From: Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?

 

W and W

CT

Ri-CT

RT-CT

RT

Ri

Responses

      

CR

 

69.2%

75%

94.7%

80.9%

57.1%

PR

 

19.2%

16.7%

5.3%

9.5%

42.9%

SD

 

0

2.8%

0

0

0

PD

 

11.6%

5.5%

0

9.5%

0

Relapse rate

-

69.2%

38.9%

84.2%

90.5%

42.9%

Median PFS 7,5 y

26%

23%

60%

26%

19%

-

Median OS 7.5y

72%

74%

74%

67%

66%

100%

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, OS overall survival, PFS progression free survival.